CD4 and tuberculosis: Triple NRTI regimens have potential advantages over standard NNRTI-based first-line regimens in Africa, as they avoid drug interactions with TB therapy, can be taken by women who may become pregnant and those with higher CD4 counts, consist of fewer pills and spare two classes for second-line after immunological/clinical failure where drug resistance is likely.